Coming October 29: SITC releases its late-breaking abstract titles. We’ll add their presenting authors’ institutions to this guide once they’re out.

Mossakowski Medical Research Institute at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Mossakowski Medical Research Institute brings 2 presentations to SITC 2026 in Phoenix. Its program centres on drugs that help immune-based treatments work better. One study uses R848 in liposomes to turn tumor-associated macrophages toward an inflammatory state, and another pushes leukemia cells to mature so that anti-CD20 therapy works better against them.

Organization	SITC 2026 Attendance
MM Mossakowski Medical Research Institute Warsaw, Poland
	Poster Fri Nov 6 12:15–1:45pm 5:30–7pm LIPOSOMAL R848 REPROGRAMS TUMOR-ASSOCIATED MACROPHAGES TOWARD A PROINFLAMMATORY PHENOTYPE AND SUPPRESSES TUMOR GROWTH IN PRECLINICAL MODELS Exhibition Halls 4-6 · Poster 851 Tumor biology · New agents Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm Pharmacologic induction of B-cell maturation sensitizes B-cell precursor acute lymphoblastic leukemia to anti-CD20 immunotherapy Exhibition Halls 4-6 · Poster 682 New agents · Tumor biology

Organization

SITC 2026 Attendance

Mossakowski Medical Research Institute

Warsaw, Poland

Poster

Fri Nov 6
12:15–1:45pm
5:30–7pm

LIPOSOMAL R848 REPROGRAMS TUMOR-ASSOCIATED MACROPHAGES TOWARD A PROINFLAMMATORY PHENOTYPE AND SUPPRESSES TUMOR GROWTH IN PRECLINICAL MODELS

Exhibition Halls 4-6 · Poster 851

Tumor biology · New agents

Poster

Sat Nov 7
12:30–1:30pm
6:40–8:10pm

Pharmacologic induction of B-cell maturation sensitizes B-cell precursor acute lymphoblastic leukemia to anti-CD20 immunotherapy